BioNTech SE (BNTX) NASDAQ
89.14
-2.56(-2.79%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 19.58B |
| Enterprise Value | 12.18B |
| P/E Ratio | -15.73 |
| PEG Ratio | 0.16 |
| Price/Sales Ratio | 7.02 |
| Price/Book Ratio | 1.05 |
| Enterprise/Revenue | 3.57 |
| Enterprise/EBITDA | -14.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.45 |
| Operating Margin | -0.52 |
Management Effectiveness
| Return On Assets | -0.06 |
| Return On Equity | -0.07 |
Income Statement
| Revenue | 2.76B |
| Revenue/Share | 11.04 |
| Gross Profit | 2.14B |
| EBITDA | -256.17M |
| Net Income | -1.09B |
| Diluted EPS | -4.51 |
Balance Sheet
| Total Cash | 14.65B |
| Total Cash/Share | 57.8 |
| Total Debt | 303.12M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 8.8 |
| Book Value Per Share | 73.82 |
Price History
| 52-Week Change | -22.92 |
| 52-Week High | 124 |
| 52-Week Low | 79.52 |
| Moving Average 50 Days | 94.77 |
| Moving Average 200 Days | 100.65 |
Statistics
| Average Volume | 1.21M |
| Shares Outstanding | 252.88M |
| % Held by Institutions | 19.61 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
